Day: August 24, 2023

NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) — MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that Dr. Jennifer Buell, Chief Executive Officer and President, will participate in the following upcoming investor conferences:Baird 2023 Global Healthcare Conference – Fireside chat will be held in-person on Tuesday, September 12th, 2023, at 12:15 p.m. ET, in New York, NY. HC Wainwright 25th Annual Global Investment Conference – Fireside chat will be held in-person on Wednesday, September 13th, 2023, at 2:30 p.m. ET, in New York, NY. A live webcast and replay will be accessible on the Events and Presentations...

P R E S S  R E L E A S E Stockholm, August 24, 2023 STOCKHOLM, SWEDEN – The Board of Directors of BTS Group AB (publ), a world-leading company in strategy execution, has today, based on an authorization from the Annual General Meeting on May 12, 2023, resolved to carry out a directed share issue of 22,472 Class B shares. The newly issued shares will be used as part payment for the previously announced acquisition of The Boda Group and will be allocated to the seller of the business. For more information about the acquisition, please refer to the press release from May 2, 2023. The issue relates to the final settlement of SEK 6,314,632 of the initial purchase price in accordance with the acquisition agreement, which was also communicated when the acquisition was announced. The reason for the deviation from the shareholders’ preferential...

COPENHAGEN, Denmark, Aug. 24, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that Jan Mikkelsen, President & Chief Executive Officer, and Scott Smith, Executive Vice President & Chief Financial Officer, will participate in three upcoming investor conferences. Details:Event Citi’s 18th Annual BioPharma ConferenceLocation Boston, MADate Thursday, September 7, 2023Time 2:40-3:25 p.m. Eastern Time / 11:40 a.m-12:25 p.m. Pacific TimeEvent 2023 Wells Fargo Healthcare ConferenceLocation Boston, MADate Friday, September 8, 2023Time 8:00-8:35 a.m. Eastern Time / 5:00-5:35 a.m. Pacific TimeEvent Morgan Stanley 21st Annual Global Healthcare ConferenceLocation New York, NYDate Tuesday, September 12, 2023Time 12:55-1:25 p.m. Eastern Time / 9:55-10:25 a.m. Pacific...

VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQB: FWEDF, formerly Fireweed Zinc Ltd.) is pleased to announce the appointment of Mr. Alex Campbell to the Management Team as Vice President Corporate Development. His role will focus on finding, evaluating, and executing strategic opportunities for the Company. CEO Statement Brandon Macdonald, CEO, stated “As Fireweed’s success at our projects has grown, so has strategic interest in the Company and options available to us. Alex’s diverse experience from mining to banking, combined with his passion for our industry, makes him a fantastic addition to the team as we navigate these opportunities. The Fireweed team is very pleased to welcome him as we continue to maximize shareholder value through exploration,...

Verizon Mobile for Microsoft Teams seen as best-in-class for driving productivity, cost, security by leading international publication NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) — Verizon Business has been recognized by UC Today, the leading international news publication honoring excellence in Unified Communications and Collaboration, as having the “Best Solution for Microsoft Teams” at the 2023 UC Today Awards. The company’s Verizon Mobile for Microsoft Teams solution, enables businesses to use their mobile phone and business number with their Microsoft Teams phone service. In January 2023, Verizon Business became the first US carrier to support Teams Phone Mobile. With this product, businesses are able to use their business smartphones and their business numbers with their Microsoft Teams phone service. This allows for major cost...

CARMEL, Ind., Aug. 24, 2023 (GLOBE NEWSWIRE) — NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today highlighted the strength of its board of directors. “We are fortunate to have a board with a depth of experience in relevant areas to NeurAxis, including medical device commercialization, commercial insurance, and finance. Mitch Watkins has led several medical device companies from start-up through commercialization, Beth Keyser has served as President of Blue Cross Blue Shield Indiana at Anthem since 2020, and Tim Henrichs has been a finance executive across industries, including healthcare,” said Brian Carrico, President and Chief Executive Officer of NeurAxis. “We...

Southlake, TX, Aug. 24, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announces that its MyoVista® wavECGTM has been selected by PanaceaFlo Ltd to be used in Dublin, Ireland in its heart screening evaluation study. The main objective of the study is to establish a cardiovascular risk screening program and integrated care hub pathway. If successful, the program is expected to roll out nationally in Ireland, in conjunction with the Irish Health Elevator Program, focusing on community-based screening and early intervention of cardiovascular risk in line with the Irish public health system...

Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults. XDEMVY is indicated for all adult patients with Demodex blepharitis and is available via prescription from an eye care provider Sales force deployed, calling on ophthalmologists and optometrists nationwide IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced that XDEMVY™ (lotilaner ophthalmic solution) 0.25% is now available at pharmacies nationwide for prescription. The U.S. Food and Drug Administration (FDA) approved XDEMVY on July 24, 2023, for the treatment of Demodex blepharitis. “We are delighted that within...